Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme.

Lancucki L, Sasieni P, Patnick J, Day TJ, Vessey MP.

J Med Screen. 2012 Jun;19(2):89-93. doi: 10.1258/jms.2012.012028. Epub 2012 May 31.

2.

Benign breast disease and subsequent breast cancer: English record linkage studies.

Goldacre MJ, Abisgold JD, Yeates DG, Vessey MP.

J Public Health (Oxf). 2010 Dec;32(4):565-71. doi: 10.1093/pubmed/fdq001. Epub 2010 Feb 12.

3.

Contraception for women. Intrauterine devices and ectopic pregnancy.

Vessey MP.

BMJ. 2009 Sep 22;339:b3864. doi: 10.1136/bmj.b3864. No abstract available.

PMID:
19773315
4.

Pregnancy outcome among twins conceived after subfertility treatment compared with natural twins: A population-based study.

Murphy MF, Neale RE, Hey K, Seagroatt VA, Goldacre MJ, Vessey MP, Willis BM, Ellis JD, Barlow DH.

Twin Res Hum Genet. 2006 Apr;9(2):279-84.

PMID:
16611499
5.

Postmarketing surveillance of the safety of cimetidine: 15-year mortality report.

Beresford J, Colin-Jones DG, Flind AC, Langman MJ, Lawson DH, Logan RF, Paterson KR, Vessey MP.

Pharmacoepidemiol Drug Saf. 1998 Sep;7(5):319-22.

PMID:
15073978
6.

Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer.

Green J, Berrington de Gonzalez A, Sweetland S, Beral V, Chilvers C, Crossley B, Deacon J, Hermon C, Jha P, Mant D, Peto J, Pike M, Vessey MP.

Br J Cancer. 2003 Dec 1;89(11):2078-86.

7.

[Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy. A follow up study].

Ulrich LS, Wells M, Sturdee DW, Barlow DH, O'Brien K, Campbell MJ, Vessey MP, Bragg AJ.

Ugeskr Laeger. 2003 Sep 8;165(37):3530-2. Danish. No abstract available.

PMID:
14531356
8.

Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.

Wells M, Sturdee DW, Barlow DH, Ulrich LG, O'Brien K, Campbell MJ, Vessey MP, Bragg AJ.

BMJ. 2002 Aug 3;325(7358):239.

9.

Copper intrauterine devices and tubal infertility among nulligravid women.

Vessey MP, Doll HA.

N Engl J Med. 2002 Jan 31;346(5):376-7. No abstract available.

10.

The community prevalence of chronic pelvic pain in women and associated illness behaviour.

Zondervan KT, Yudkin PL, Vessey MP, Jenkinson CP, Dawes MG, Barlow DH, Kennedy SH.

Br J Gen Pract. 2001 Jul;51(468):541-7.

11.

Chronic pelvic pain in the community--symptoms, investigations, and diagnoses.

Zondervan KT, Yudkin PL, Vessey MP, Jenkinson CP, Dawes MG, Barlow DH, Kennedy SH.

Am J Obstet Gynecol. 2001 May;184(6):1149-55.

PMID:
11349181
12.

The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.

Sturdee DW, Ulrich LG, Barlow DH, Wells M, Campbell MJ, Vessey MP, Nielsen B, Anderson MC, Bragg AJ.

BJOG. 2000 Nov;107(11):1392-400. Erratum in: BJOG 2001 Mar;108(3):335.

14.

Hormonal and other factors in relation to survival among breast cancer patients.

Reeves GK, Patterson J, Vessey MP, Yeates D, Jones L.

Int J Cancer. 2000 May 20;89(3):293-9.

15.

Polycystic ovaries and associated clinical and biochemical features in young women.

Michelmore KF, Balen AH, Dunger DB, Vessey MP.

Clin Endocrinol (Oxf). 1999 Dec;51(6):779-86.

PMID:
10619984
16.

Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs.

Weil J, Langman MJ, Wainwright P, Lawson DH, Rawlins M, Logan RF, Brown TP, Vessey MP, Murphy M, Colin-Jones DG.

Gut. 2000 Jan;46(1):27-31.

17.

Patterns of diagnosis and referral in women consulting for chronic pelvic pain in UK primary care.

Zondervan KT, Yudkin PL, Vessey MP, Dawes MG, Barlow DH, Kennedy SH.

Br J Obstet Gynaecol. 1999 Nov;106(11):1156-61.

PMID:
10549960
18.

Prevalence and incidence of chronic pelvic pain in primary care: evidence from a national general practice database.

Zondervan KT, Yudkin PL, Vessey MP, Dawes MG, Barlow DH, Kennedy SH.

Br J Obstet Gynaecol. 1999 Nov;106(11):1149-55.

PMID:
10549959
19.

Oral contraception and health.

Vessey MP.

Br J Gen Pract. 1998 Oct;48(435):1639-40. No abstract available.

20.

Prescription of proton pump inhibitors. Indications may be more specific than suggested by GP records.

Mant J, Murphy MF, Vessey MP.

BMJ. 1999 Feb 20;318(7182):534. No abstract available.

PMID:
10094541
21.

Oral contraception and eye disease: findings in two large cohort studies.

Vessey MP, Hannaford P, Mant J, Painter R, Frith P, Chappel D.

Br J Ophthalmol. 1998 May;82(5):538-42.

22.

Use of the Short Form-36 to detect the influence of upper gastrointestinal disease on self-reported health status.

Mant JW, Jenkinson C, Murphy MF, Clipsham K, Marshall P, Vessey MP.

Qual Life Res. 1998 Apr;7(3):221-6.

PMID:
9584552
23.

The prevalence of chronic pelvic pain in women in the United Kingdom: a systematic review.

Zondervan KT, Yudkin PL, Vessey MP, Dawes MG, Barlow DH, Kennedy SH.

Br J Obstet Gynaecol. 1998 Jan;105(1):93-9.

PMID:
9442169
24.

Quality of life and patient preference for sequential versus continuous combined HRT: the UK Kliofem multicenter study experience. UK Continuous Combined HRT Study Investigators.

Ulrich LG, Barlow DH, Sturdee DW, Wells M, Campbell MJ, Nielsen B, Bragg AJ, Vessey MP.

Int J Gynaecol Obstet. 1997 Oct;59 Suppl 1:S11-7.

PMID:
9386211
25.

Evaluation of computer support for prescribing (CAPSULE) using simulated cases.

Walton RT, Gierl C, Yudkin P, Mistry H, Vessey MP, Fox J.

BMJ. 1997 Sep 27;315(7111):791-5.

26.

Combined oral contraceptives and liver disease.

Hannaford PC, Kay CR, Vessey MP, Painter R, Mant J.

Contraception. 1997 Mar;55(3):145-51.

PMID:
9115002
27.

Effect of endogenous and exogenous hormones on breast cancer: epidemiology.

Vessey MP.

Verh Dtsch Ges Pathol. 1997;81:493-501. Review.

PMID:
9474890
28.

Case-control study of venous thromboembolism risk in users of hormone replacement therapy.

Daly E, Vessey MP, Painter R, Hawkins MM.

Lancet. 1996 Oct 12;348(9033):1027. No abstract available.

PMID:
8855869
29.

Risk of venous thromboembolism in users of hormone replacement therapy.

Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S.

Lancet. 1996 Oct 12;348(9033):977-80.

PMID:
8855852
30.
31.

Hormone replacement therapy in a risk-benefit perspective.

Daly E, Vessey MP, Barlow D, Gray A, McPherson K, Roche M.

Maturitas. 1996 Mar;23(2):247-59.

PMID:
8735363
33.

Follow up in breast cancer. Quality of life unaffected by general practice follow up.

Grunfeld E, Yudkin P, Adewuyl-Dalton R, Vessey MP, Mant D.

BMJ. 1995 Jul 1;311(6996):54. No abstract available.

34.
35.

Specialist and general practice views on routine follow-up of breast cancer patients in general practice.

Grunfeld E, Mant D, Vessey MP, Fitzpatrick R.

Fam Pract. 1995 Mar;12(1):60-5.

PMID:
7665044
36.

Evaluating primary care follow-up of breast cancer: methods and preliminary results of three studies.

Grunfeld E, Mant D, Vessey MP, Yudkin P.

Ann Oncol. 1995;6 Suppl 2:47-52. Review.

PMID:
8547197
37.

Is screening for ovarian cancer worthwhile?

Vessey MP.

J Med Screen. 1995;2(1):57. No abstract available.

PMID:
7497150
38.

The epidemiology of carcinoid tumours in England and Scotland.

Newton JN, Swerdlow AJ, dos Santos Silva IM, Vessey MP, Grahame-Smith DG, Primatesta P, Reynolds DJ.

Br J Cancer. 1994 Nov;70(5):939-42.

39.

Mammography after treatment for breast cancer.

Grunfeld E, Mant D, Vessey MP, Cole DJ, Stewart JA.

BMJ. 1994 Sep 10;309(6955):665-6. No abstract available.

41.

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.

Langman MJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF, Murphy M, Vessey MP, Colin-Jones DG.

Lancet. 1994 Apr 30;343(8905):1075-8. Erratum in: Lancet 1994 May 21;343(8908):1302.

PMID:
7909103
42.

Ovarian and endometrial cancers.

Mant JW, Vessey MP.

Cancer Surv. 1994;19-20:287-307. Review.

PMID:
7895220
43.

Peptic ulcer, cimetidine, and motor neurone disease--a record linkage study.

Vessey MP, Goldacre MJ, Seagroatt V, Yeates D.

Gut. 1993 Dec;34(12):1660-1.

46.

Misoprostol and illegal abortion in Rio de Janeiro, Brazil.

Costa SH, Vessey MP.

Lancet. 1993 May 15;341(8855):1258-61.

PMID:
8098402
47.

Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk.

Jha PK, Beral V, Peto J, Hack S, Hermon C, Deacon J, Mant D, Chilvers C, Vessey MP, Pike MC, et al.

Lancet. 1993 May 1;341(8853):1116-8.

PMID:
8097804
48.

Benefits and risks of combined oral contraceptives.

Vessey MP.

Methods Inf Med. 1993 Apr;32(3):222-4. Review.

PMID:
8341154
49.

A retrospective cohort study of vasectomy and prostate cancer in US men.

Giovannucci E, Tosteson TD, Speizer FE, Ascherio A, Vessey MP, Colditz GA.

JAMA. 1993 Feb 17;269(7):878-82.

PMID:
8123059
50.

Oral contraceptives and reproductive factors in multiple sclerosis incidence.

Villard-Mackintosh L, Vessey MP.

Contraception. 1993 Feb;47(2):161-8.

PMID:
8449016

Supplemental Content

Loading ...
Support Center